SEC Form 4 · accession 0001179110-16-026458
Neos Therapeutics, Inc. · NEOS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Juergen Martens
Officer — Chief Tech/Operations Officer
Period of report
Jun 13, 2016
Accepted (ET)
Jun 14, 2016 · 4:25 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001467652
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 13, 2016 | P | 10,000 | $9.90 | A | 10,000 | D |
Table II — derivative securities
No Table II lines on this filing.